menu
    • menu

    Company profile for Palliative Care

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    The PCC leadership come from a pharmacy and healthcare background which gives us a clinical approach to patient management

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Palliative CareUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    17822 Beach Blvd, Ste 321, Huntington Beach, California, 92647
    Telephone
    Telephone
    (888) 702-7378
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://pccorp.org/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    VITAS® Healthcare Announces CEO Appointment and Transition
    VITAS® Healthcare Announces CEO Appointment and Transition

    30 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/30/3124474/0/en/VITAS-Healthcare-Announces-CEO-Transition-and-Appointment-of-New-Chief-Executive-Officer.html

    GLOBENEWSWIRE
    30 Jul 2025
    Share Share
    India Invites EoI to Build Cancer TRH for Evidence-Based Care
    India Invites EoI to Build Cancer TRH for Evidence-Based Care

    23 Jun 2025

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=178647&sid=1

    PHARMABIZ
    23 Jun 2025
    Share Share
    Sensei Bio Reports Positive Data For Solnerstotug In PD-(L)1 Tumors
    Sensei Bio Reports Positive Data For Solnerstotug In PD-(L)1 Tumors

    27 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/27/3051000/0/en/Sensei-Biotherapeutics-Reports-Favorable-Preliminary-Dose-Expansion-Data-for-Solnerstotug-in-PD-L-1-Resistant-Tumors.html

    GLOBENEWSWIRE
    27 Mar 2025
    Share Share
    Avextra Backs Landmark Psilocybin Therapy Study In Palliative Care
    Avextra Backs Landmark Psilocybin Therapy Study In Palliative Care

    20 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/20/3000758/0/en/Avextra-Backs-Landmark-Psilocybin-Therapy-Study-in-Palliative-Care.html

    GLOBENEWSWIRE
    20 Dec 2024
    Share Share
    Psyence Biomedical Initiates Australian Trial Site
    Psyence Biomedical Initiates Australian Trial Site

    16 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/16/2946746/0/en/Psyence-Group-s-NASDAQ-Listed-Associate-Psyence-Biomedical-Announces-Initiation-of-First-Trial-Site-in-Australia-for-its-Phase-IIb-Study-of-Nature-Derived-Psilocybin-as-a-Potential.html

    GLOBENEWSWIRE
    16 Sep 2024
    Share Share
    Psyence Biomed Initiates First Trial Site In Australia
    Psyence Biomed Initiates First Trial Site In Australia

    09 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/09/2942714/0/en/Psyence-Biomed-Announces-Initiation-of-First-Trial-Site-in-Australia-for-its-Phase-IIb-Study-of-Nature-Derived-Psilocybin-as-a-Potential-Treatment-for-Adjustment-Disorder-in-Pallia.html

    GLOBENEWSWIRE
    09 Sep 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search